Disease Resurgence, Production Capability Issues and Safety Concerns in the Context of an Aging Population: Is There a Need for a New Yellow Fever Vaccine?

Por Tomashek, Kay M., Challberg, Mark, Nayak, Seema U., Schiltz, Helen F.
Publicado no Vaccines (Basel) (2019)

The development and approval of tecoviromat (TPOXX(®)), the first antiviral against smallpox

Por Merchlinsky, Michael, Albright, Andrew, Olson, Victoria, Schiltz, Helen, Merkeley, Tyler, Hughes, Claiborne, Petersen, Brett, Challberg, Mark
Publicado no Antiviral Res (2019)

Challenges, Progress, and Opportunities: Proceedings of the Filovirus Medical Countermeasures Workshop

Por Hirschberg, Rona, Ward, Lucy A., Kilgore, Nicole, Kurnat, Rebecca, Schiltz, Helen, Albrecht, Mark T., Christopher, George W., Nuzum, Ed
Publicado em 2014